Nonmuscle Invasive Bladder Cancer: Guidelines for Treatment

To start this activity, click Begin at the bottom of this pageNonmuscle Invasive Bladder 
Cancer: Guidelines for Treatment

Release Date: November 2012

Expiration Date: November 2013

Estimated time to complete the educational activity: 1 hour

This activity is jointly sponsored by Medical Education Resources and Haymarket Medical Education.

Statement of Need: Urologists who care for patients with NMIBC must incorporate established clinical practice guidelines for treatment, and, in doing so, reduce the current substantive and inappropriate variation in practice patterns surrounding NMIBC. Improving guideline adherence will close the gap on inappropriate care delivery.

Target Audience: This activity has been designed to meet the educational needs of urologists and allied healthcare professionals who treat patients with bladder cancer.

Educational Objectives: After completing the activity, the participant should be better able to:

  • Review the content and development process of clinical practice guidelines for NMIBC.
  • Review data surrounding poor adherence to guidelines, which will serve as a cue to action for urologists to improve guideline adherence.

Accreditation Statement:This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Medical Education Resources (MER) and Haymarket Medical Education. MER is accredited by the ACCME to provide -continuing medical education for physicians.

Credit Designation: Medical Education Resources designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest: Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all its educational programs. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure all scientific research referred to, reported, or used in a CME activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality CME activities that promote improvements or quality in health care and not a commercial interest.

The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this CME activity:

Name of Faculty Reported Financial Relationship
Matthew J. Resnick, MD Consultant: Bayer Healthcare, Dendreon
Michael S. Cookson, MD Consultant: Takeda Photocure, Endo Pharmaceuticals

The content managers, Jody A. Charnow and Marina Galanakis, of Haymarket Medical Education, and Julie Johnson, PharmD, of Medical Education Resources, have disclosed that they have no relevant financial relationships or conflicts of interest.

Method of Participation: There are no fees for participating in and receiving CME credit for this activity. During the period November 2012 through November 2013, participants must: 1) read the learning objectives and faculty disclosures, 2) study the educational activity, 3) complete the posttest and submit it online. Physicians may register at www.myCME.com/renalandurologynews, and 4) complete the evaluation form online.

A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed post-test with a score of 70% or better.

Page 1 of 6
Loading links....
You must be a registered member of Renal and Urology News to post a comment.